CDKN2A deletion as a prognostic marker: A clinico-genomic analysis of sarcoma patients. Nam Bui, Przybyl, J., Million, L., Van De Rijn, M., Ganjoo, K. N. AMER SOC CLINICAL ONCOLOGY. 2018

View details for DOI 10.1200/JCO.2018.36.15_suppl.11543

View details for Web of Science ID 000442916003625